Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 12Neoplasms 7Breast Neoplasms 4Hypogonadism 3Eunuchism 3Testicular Neoplasms 2Polycystic Ovary Syndrome 2Obesity 2Metabolic Syndrome 2Fatigue 2Dyspareunia 2Vaginitis 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Sexuality 1Sexual Dysfunction, Physiological 1Sarcopenia 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Metabolic Diseases 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Infertility 1Hot Flashes 1Diabetes Mellitus 1Colorectal Neoplasms 1Cardiovascular Diseases 1

Interventions

Testosterone Propionate 1Testosterone 1Surveys and Questionnaires 1Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Vaginitis × Testosterone × Clear all
NCT01122342 2010-05-13

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

University of Vermont

Phase 1/2 Suspended
30 enrolled
Breast

Breast Neoplasms, Dyspareunia, Vaginitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡